CAPTRUST Financial Advisors’s Cardiff Oncology CRDF Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-409	Closed	-$1K	–	2469
2022 Q2	$1K	Hold	409	–	–	﹤0.01%	4653
2022 Q1	$1K	Hold	409	–	–	﹤0.01%	4670
2021 Q4	$2K	Sell	409 -451	-52%	-$2.69K	﹤0.01%	4393
2021 Q3	$6K	Hold	860	–	–	﹤0.01%	3858
2021 Q2	$6K	Hold	860	–	–	﹤0.01%	3770
2021 Q1	$8K	Buy	860 +300	+54%	+$3.65K	﹤0.01%	3529
2020 Q4	$10K	Sell	560 -75	-12%	-$1.32K	﹤0.01%	2560
2020 Q3	$9K	Hold	635	–	–	﹤0.01%	2318
2020 Q2	$3K	Buy	+635	New	+$1.3K	﹤0.01%	2498
2019 Q4	–	Sell	-785	Closed	-$1K	–	1162
2019 Q3	$1K	Hold	785	–	–	﹤0.01%	1854
2019 Q2	$2K	Hold	785	–	–	﹤0.01%	1791
2019 Q1	$3K	Hold	785	–	–	﹤0.01%	1617
2018 Q4	$2K	Sell	785 -83	-10%	-$378	﹤0.01%	1476
2018 Q3	$4K	Hold	868	–	–	﹤0.01%	1385
2018 Q2	$4K	Hold	868	–	–	﹤0.01%	1342
2018 Q1	$22K	Hold	868	–	–	﹤0.01%	798
2017 Q4	$19K	Hold	868	–	–	﹤0.01%	796
2017 Q3	$22K	Buy	+868	New	+$54.1K	﹤0.01%	353

Other funds holding CRDF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CAPTRUST Financial Advisors's CRDF Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Cardiff Oncology (CRDF) in Q3 2022, closing a stake of 409 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in CRDF in Q3 2017 and held it in 18 quarters. The position peaked at $22K in Q1 2018. 58 funds tracked by Wall St. Rank hold CRDF as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Cardiff Oncology position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 409 Cardiff Oncology shares in Q3 2022, an estimated $1K.
CAPTRUST Financial Advisors first reported a position in Cardiff Oncology in Q3 2017 and held it in 18 quarters.
CAPTRUST Financial Advisors's Cardiff Oncology position peaked at $22K in Q1 2018.
58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.